Absolute Bioavailability of Reslizumab in Healthy Subjects
- Study Title
- Absolute Bioavailability of Reslizumab in Healthy Subjects
- Teva Identifier
- C38072/1107
- ClinicalTrials.gov Identifier
- NCT01990443
- Study Status
- Completed
- Trial Condition(s)
- Absolute Bioavailability
- Interventions
- Drug: Reslizumab IV | Drug: Reslizumab SC
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 45 Years
- Trial Duration
- 06/01/2013 - 03/01/2014
- Phase
- Phase 1
